Central and peripheral evaluation of rupatadine, a new antihistamine/ platelet-activating factor antagonist, at different doses in healthy volunteers

Neuropsychobiology

Volumn 50, Issue 4, 2004, Pages 311-321

  Barbanoj, Manel J ^a,b,d   García Gea, Consuelo ^a,b   Morte, Adelaida ^a,b   Izquierdo, Iñaki ^c   Pérez, Iñaki ^c   Jané, Francesc ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Grupo Uriach   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Antihistamine sedation; Histamine wheal; Hydroxyzine; Psychomotor function; Rupatadine

Indexed keywords

ANTIHISTAMINIC AGENT; HYDROXYZINE; RUPATADINE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ADULT; ARTICLE; ATTENTION; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MENTAL FUNCTION; MOOD; NORMAL HUMAN; PERCEPTION; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SINGLE DRUG DOSE; SKIN ALLERGY; URTICARIA;

ADULT; ANALYSIS OF VARIANCE; ATTENTION; CROSS-OVER STUDIES; CYPROHEPTADINE; DECISION MAKING; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; FEMALE; FLICKER FUSION; FOLLOW-UP STUDIES; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HUMANS; HYDROXYZINE; MALE; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; PAIN MEASUREMENT; PLATELET ACTIVATING FACTOR; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SELF ASSESSMENT (PSYCHOLOGY); SKIN TESTS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 8344261734     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080959     Document Type: Article

References (53)

1. Baraniuk JN: Mechanisms of allergic rhinitis. Curr Allergy Asthma Rep 2001;1:207-217.
2. Sobol SE, Christodoulopoulos P, Hamid QA: Inflammatory patterns of allergic and nonallergic rhinitis. Curr Allergy Asthma Rep 2001;1:193-201.
3. Schwartz LB: Mast cells and basophils. Clin Allergy Immunol 2002;16:3-42.
4. Alam R, Kampen G: Cytokines in allergic inflammation. Clin Allergy Immunol 2002;16:255-274.
5. Pawankar R, Yamagishi S, Yagi T: Revisiting the roles of mast cells in allergic rhinitis and its relation to local IgE synthesis. Am J Rhinol 2000;14:309-317.
6. Christie PE, Henderson WR Jr: Lipid inflammatory mediators: Leukotrienes, prostaglandins, platelet-activating factor. Clin Allergy Immunol 2002;16:233-254.
7. Akagi M, Kanoh R, Fukuishi N, Tachibana M, Akagi R: Contribution of platelet activating factor (PAF) in histamine-induced model of nasal allergy in rats. Arerugi 1995;44:182-188.
8. Carceller E, Merlos M, Giral M, Balsa D, Almansa C, Bartroli J, Garcia-Rafanell J, Forn J: [(3-Pyridylalkyl)piperidylidene] benzocycloheptapyridine derivatives as dual antagonists of PAF and histamine. J Med Chem 1994;37:2697-2703.
9. Merlos M, Giral M, Balsa D, Ferrando R, Queralt M, Puigdemont A, Garcia-Rafanell J, Forn J: Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). J Pharmacol Exp Ther 1997;280:114-121.
10. Queralt M, Brazis P, Merlos M, de Mora F, Puigdemont A: In vitro inhibitory effect of rupatadine on histamine and TNF-alpha release from dispersed canine skin mast cells and the human mast cell line HMC-1. Inflamm Res 2000;49:355-360.
11. Peck AW, Fowler ASE, Bye C: A comparison of triprolidine and clemastine on histamine antagonism and performance tests in man: Implications for the mechanism of drug-induced drowsiness. Eur J Clin Pharmacol 1975;8:455-463.
12. Carruthers SG, Shoeman DW, Hignite CE, Azarnoff DL: Correlation between plasma diphenhydramine level and sedative and antihistamine effects. Clin Pharmacol Ther 1978;23:375-382.
13. Clarke CH, Nicholson AN: Performance studies on antihistamines. Br J Clin Pharmacol 1978;6:31-35.
14. Nicholson AN, Stone BM: Performance studies with the H1-histamine receptor antagonists, astemizole and terfenadine. Br J Clin Pharmacol 1982;1:199-202.
15. Nicholson AN, Stone BM: Antihistamines: Impaired performance and the tendency to sleep. Eur J Clin Pharmacol 1986;30:27-32.
16. 1-receptor antagonists (the antihistamines). Clin Pharmacokinet 1985;10:477-497.
17. Rombaut NE, Bhatti JZ, Alford C, Curran S, Hindmarch I: Psychopharmacological aspects of antihistamines. Pharmacopsychoecologica 1989;2:21-30.
18. Weiner M: Sedation and antihistamines. Arzneimittelforschung 1982;32:1193-1195.
19. Richads DM, Brogden RN, Heel RC, Speight TM, Avery GS: Astemizole: A review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1984;28:38-61.
20. Vincent J, Summer DJ, Reid JL: Ebastine: The effect of a new antihistamine on psychomotor performance and autonomic responses in healthy subjects. Br J Clin Pharmcol 1988;26:503-508.
21. McTavish D, Goa KL, Ferrill M: Terfenadine: An updated review of its pharmacological properties and therapeutic efficacy. Drugs 1990;39:552-574.
22. Campoli-Richards DM, Buckley MMT, Fitton A: Cetirizine: A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria. Drugs 1990;40:762-781.
23. Levander S, Hagermark O, Stahle M: Peripheral antihistamine and central sedative effects of three H1-receptor antagonists. Eur J Clin Pharmacol 1985;28:523-529.
24. Pechadre JC, Beudin P, Eschalier A, Trolese JF, Rihoux JP: A comparison of central and peripheral effects of cetirizine and loratadine. J Int Med Res 1991;19:289-295.
25. Huther KJ, Renftle G, Barrand N, Burke JT, Kich-Weser J: Inhibitory activity of terfenadine on histamine-induced skin wheals in man. Eur J Clin Pharmacol 1997;12:195-199.
26. Bateman DN, Chapman PH, Rawlins MD: The effects of astemizole on histamine-induced weal and flare. Eur J Clin Pharmacol 1983;25:547-551.
27. Cohen AF, Hamilton MJ, Liao SHT, Findlay JWA, Peck AW: Pharmacodynamics and pharmacokinetics of BW 825C: A new antihistamine. Eur J Clin Pharmacol 1985;28:197-204.
28. Hindmarch I: Psychomotor function and psychoactive drugs. Br J Clin Pharmacol 1980;10:189-209.
29. Hindmarch I: Psychometric of drug effects in volunteers and patients. Pharm Med 1988;3:135-142.
30. Meltzer EO: Performance effects of antihistamines. J Allergy Clin Immunol 1990;86:613-619.
31. Barbanoj MJ, Lorenzo JL, Clos S, García-Gea C, Jané F: Proof of safety of drugs: focus on vigilance. Methods Find Exp Clin Pharmacol 2002;24(suppl C):51-64.
32. Luria RE: The validity of the visual analogue mood scale. J Psychiatr Res 1975;12:51-57.
33. Hindmarch I, Gudgeon AC: The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability. Br J Clin Pharmacol 1980;10:145-150.
34. Parrot AC, Hindmarch I: The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations - A review. Psychopharmacology (Berl) 1980;71:173-179.
35. Parrot AC, Hindmarch I: Factor analysis of a sleep evaluation questionnaire. Psychol Med 1978;8:325-329.
36. Zisapel N, Laudon M: Subjective assessment of the effects of CNS-active drugs on sleep by the Leeds Sleep Evaluation Questionnaire: A review. Hum Psychopharmacol 2003;18:1-20.
37. Dolley CT, Davies DS, Draffan GH, Dargie HJ, Reid JL: Clinical pharmacology and pharmacokinetics of clonidine. Clin Pharmacol Ther 1976;19:11-17.
38. Lorenzo JL, Barbanoj MJ: Variability of sleep parameters across multiple laboratory sessions in healthy young subjects: The 'very first night effect'. Psychophysiology 2002;39:409-413.
39. Izquierdo I, Nieto C, Ramis J, Cooper M, Dewland P, Forn J: Pharmacokinetic and dose linearity of rupatadine fumarate in healthy volunteers. Methods Find Exp Clin Pharmacol 1997;19(suppl A):189.
40. Vincent J, Limiñana R, Meredith PA, Reid JL: The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects. Br J Clin Pharmacol 1988;26:497-501.
41. Porter CC, Arisen BH, Gruber VF, Titus DC, Vanderheuvel WJA: Human metabolism of cyproheptadine. Drug Metab Dispos 1975;3:189-197.
42. Gengo FM, Dabronzo J, Yurchak A, Love S, Miller JK: The relative antihistamine and psychomotor effects of hydroxyzine and cetirizine. Clin Pharmacol Ther 1987;42:265-272.
43. Geha RS, Meltzer EO: Desloratadine: A new, nonsedating, oral antihistamine. J Allergy Clin Immunol 2001;107:751-762.
44. Pishkin V, Sengel RA, Lovallo WR, Shurley JT: Cognitive and psychomotor evaluation of clemastine, diphenhydramine HCl, and hydroxyzine in a double-blind study. Curr Ther Res 1983;33:230-247.
45. Burns M, Moskowitz H: Effects of diphenhydramine and alcohol on skills performance. Eur J Clin Pharmacol 1980;17:259-266.
46. Seppala T, Nuotto E, Korttila K: Single and repeated dose comparison of three antihistamines and phenylpropanolamine psychomotor performance and subjective appraisal of sleep. Br J Clin Pharmacol 1981;12:179-188.
47. Perez I, Villa M, De la Cruz G, Izquierdo I: Rupatadine in allergic rhinitis: Pooled analysis of efficacy data. Allergy 2002;57:245.
48. Krause L, Shuster S: Mechanism of action of antipruritic drugs. Br Med J 1983;287:1199-1200.
49. Kulsrestha VK, Grupta PP, Turner P, Wadsworth J: Some clinical pharmacological studies with terfenadine, a new antihistamine drug. Br J Clin Pharmacol 1978;6:25-29.
50. Mattila MJ, Mattila M, Komo K: Acute and subacute actions on human performance and interactions with diazepam of temelastine (SK&F93944) and diphenhydramine. Eur J Clin Pharmacol 1986;31:291-298.
51. Bilzer W, Gundert-Remy U, Weber E: Relationship between antihistaminic activity and plasma levels of diphenhydramine. Eur J Clin Pharmacol 1974;7:393-395.
52. Brion N, Beaumont D, Advenier C: Evaluation of the antimuscarinic activity of atropine, terfenadine and mequitazine in healthy volunteers. Br J Clin Pharmacol 1988;25:27-32.
53. Flett SR, Szbadi E, Bradshaw CM: A comparison of the effects of fluvoxamine and amitriptyline on autonomic functions in healthy volunteers. Eur J Clin Pharmacol 1992;42:529-533.